Vigil Neuroscience is incorporated in Delaware.
Vigil Neuroscience priced its initial public offering (IPO) on January 6, 2022. Vigil’s common stock began trading on January 7, 2022.
Vigil Neuroscience is traded on the Nasdaq Global Market under the symbol “VIGL”.
Vigil Neuroscience’s fiscal year-end is December 31st.
Vigil’s transfer agent is:
Computershare Trust Company, N.A.
150 Royal Street
Canton, Massachusetts 02021
1- 800-962-4284
Vigil Neuroscience’s independent auditor is PricewaterhouseCoopers LLP located in Boston, MA.
Vigil Neuroscience’s outside legal counsel is Goodwin Procter LLP located in Boston, MA.
Vigil Neuroscience’s press release archives can be viewed here.
Vigil Neuroscience SEC filings can be found on www.sec.gov and are also available here.
Our stockholders’ meeting will be held annually. Instructions on how to attend will be mailed to all stockholders.
Please email investors@vigilneuro.com for assistance.
To find out more about us, visit our webpage at www.vigilneuro.com or sign up here to receive email alerts.